Fig. 2From: The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac deathUnadjusted primary endpoint incidence per 1000 person-years according to the extent of LGEBack to article page